PINL:GRPOF - Post by User
Post by
KnowledgeBaseon Nov 06, 2018 2:10pm
250 Views
Post# 28932172
NR's and How it is done!
NR's and How it is done!I tend to agree with Leaf on this one. TBP is not a major pharma player at this point. Rather there a fairly new company with some potentially profitable concepts in an underdeveloped market. This is why I am holding my shares. I like communication from the company to it's shareholders, which TBP does after they complete each action. They do not focus on pumping up each milestone, rather they focus on completing them.
I understand your frustration with this method as it results in a SP lag because there isn't anyone pumping each step they take. However I would rather them focus on their pipeline and get their products successfully to the market. Once they achieve that milestone then it's time to get noticed, however by that time anyone with real money will already be hopping in. This is just how it's done when you're smaller pharma new to the sector. I stand by my statement earlier though, I'm sure there will be benefits to the PNG purchase but I'm when I run my CBA on the details that are known it just doesn't seem to match the 12 Million spent given today's valuation. I hope leaf is right and we can use their patant and product line to launch a more valuable proposition moving forward and perhaps spin it off after doing so for a mutiple of what was spent.